PRVL News and Press, Prevail Therapeutics Inc. From 01/05/21

NEW YORK, NY / ACCESSWIRE / January 5, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: RealPage, Inc. (NASDAQ:RP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties rel...

Merger activity decreased last week with one new deal announced. The acquisition of Red Lion Hotels (RLH) by Sonesta International Hotels. Perella Weinberg Partners and FinTech Acquisition Corp. IV enter into a definitive business combination agreement. For further details s...

Merger activity remained steady last week with seven new deals announced. The acquisition of RealPage by Thoma Bravo. The acquisition of QEP Resources by Diamondback Energy. For further details see: Merger Arbitrage Mondays: Deal-Making In 2020 Ends With A Bang

NEW YORK, NY / ACCESSWIRE / December 23, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cardtronics plc (NASDAQ:CATM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties rel...

M&A momentum continued to build with seven new deals announced. Lockheed Martin Corporation (LMT) announced that it is acquiring Aerojet Rocketdyne Holdings (AJRD). The acquisition of TC PipeLines (TCP) by TC Energy Corporation (TRP). For further details see: Merger ...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks snapped their three-day advance with small losses Friday in volatile quadruple witching trading, as progress stalled on a COVID financ...

With an upgrade to revenue guidance, acquisition, and now analysts raising their price targets, Eli Lilly (LLY) seems to have hit a purple patch.Yesterday’s announcements for its acquisition of Prevail Therapeutics (PRVL) and then the upgrade to 2020 financial guidance have followed to...

Shares of Eli Lilly (NYSE: LLY) jumped by 6% on Tuesday. The healthy gain came after the drugmaker raised its full-year 2020 revenue and earnings guidance, and provided a positive outlook for 2021. Lilly also announced plans to acquire Prevail Therapeutics (NASDAQ: PRVL) . ...

Eli Lilly (NYSE: LLY) will soon add a new asset to its portfolio. The veteran pharmaceutical company announced on Tuesday that it has signed a definitive agreement to acquire gene therapy specialist Prevail Therapeutics (NASDAQ: PRVL) . The price is $22.50 per share in c...

Gainers: Anchiano Therapeutics (ANCN) +142%.BioCardia (BCDA) +87%.Prevail Therapeutics (PRVL) +81%.Solid Biosciences (SLDB) +36%.OncoCyte (OCX) +24%.Bridgetown (BTWN) +23%.Contango Oil & Gas (MCF) +22%.Immutep (IMMP) +22%.MicroVision (MVIS) +20%.Sio Gene Therapies (SIOX) +1...